- Home
- EXR vs RVMD Comparison
EXR vs RVMD Comparison
Compare EXR & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXR | RVMD |
|---|---|---|
| Founded | 1977 | 2014 |
| Country | United States | United States |
| Employees | N/A | 883 |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.3B | 30.1B |
| IPO Year | 2004 | N/A |
Fundamental Metrics
Financial Performance| Metric | EXR | RVMD |
|---|---|---|
| Price | $145.23 | $156.08 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 19 |
| Target Price | ★ $144.80 | $140.84 |
| AVG Volume (30 Days) | 855.4K | ★ 2.3M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 4.61% | N/A |
| EPS Growth | ★ 13.90 | N/A |
| EPS | ★ 1.14 | N/A |
| Revenue | ★ $3,377,542,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.63 | $533.02 |
| P/E Ratio | $125.47 | ★ N/A |
| Revenue Growth | ★ 3.70 | N/A |
| 52 Week Low | $125.71 | $34.00 |
| 52 Week High | $155.19 | $166.50 |
Technical Indicators
Market Signals| Indicator | EXR | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 55.89 | 57.65 |
| Support Level | $136.53 | $93.39 |
| Resistance Level | $145.69 | N/A |
| Average True Range (ATR) | 3.28 | 6.18 |
| MACD | 0.01 | -0.61 |
| Stochastic Oscillator | 78.13 | 56.00 |
Price Performance
Historical ComparisonAbout EXR Extra Space Storage Inc
Extra Space Storage is a fully integrated real estate investment trust that owns, operates, and manages more than 4,200 self-storage properties in 43 states, with over 330 million net rentable square feet of storage space. Of these properties, approximately one half is wholly owned, while some facilities are owned through joint ventures and others are owned by third parties and managed by Extra Space Storage in exchange for a management fee.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.